organization · Reporting owner
LILLY ENDOWMENT INC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ELI LILLY & Co
Report date May 06, 2026 · Filed May 07, 2026
Section 16 reporting ended · disclosed 2026-05-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,881,150 |
Ending reported balance
After 2026-05-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-06 · Sale · Disposed 13,620 · Balance 91,883,358 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4. Row 2 · 2026-05-06 · Sale · Disposed 2,208 · Balance 91,881,150 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 06, 2022 Filed Apr 7, 2022 16:44 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 4,020 | $299.13 | $1,202,498.58 |
DisclosureSEC source: 0001209191-22-023608 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,817,049 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $298.56 to $299.5513, inclusive. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 16:44 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 6,652 | $298.00 | $1,982,322.61 |
DisclosureSEC source: 0001209191-22-023608 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,821,069 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $297.56 to $298.50, inclusive. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 16:44 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,467 | $297.13 | $1,624,393.31 |
DisclosureSEC source: 0001209191-22-023608 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,827,721 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $296.56 to $297.5577, inclusive. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 16:44 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,473 | $296.04 | $732,097.03 |
DisclosureSEC source: 0001209191-22-023608 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,833,188 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $295.56 to $296.5578, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10) and (11) to this Form 4. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 18:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 6,534 | $295.34 | $1,929,764.63 |
DisclosureSEC source: 0001209191-22-023450 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,835,661 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $295.00 to $295.78, inclusive. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 18:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 38,039 | $294.49 | $11,202,219.23 |
DisclosureSEC source: 0001209191-22-023450 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,842,195 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $294.00 to $294.9961, inclusive. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 18:35 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 69,183 | $293.37 | $20,296,355.08 |
DisclosureSEC source: 0001209191-22-023450 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,880,234 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.00 to $293.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| April 04, 2022 Filed Apr 5, 2022 18:31 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 39,393 | $293.15 | $11,548,136.74 |
DisclosureSEC source: 0001209191-22-022913 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,949,417 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.00 to $293.58, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 18:34 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,000 | $293.02 | $293,019.00 |
DisclosureSEC source: 0001209191-22-022249 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,988,810 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.005 to $293.14, inclusive. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 18:34 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 164,376 | $292.38 | $48,059,761.75 |
DisclosureSEC source: 0001209191-22-022249 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,989,810 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.00 to $292.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 16:51 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,500 | $292.03 | $730,075.00 |
DisclosureSEC source: 0001209191-22-021707 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,154,186 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.00 to $292.19, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 20:37 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 100 | $293.00 | $29,300.00 |
DisclosureSEC source: 0001209191-22-021598 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,156,686 Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 20:37 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 4,241 | $292.37 | $1,239,953.89 |
DisclosureSEC source: 0001209191-22-021598 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,156,786 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.00 to $292.85 , inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 28, 2022 Filed Mar 29, 2022 18:14 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 7,538 | $292.16 | $2,202,264.39 |
DisclosureSEC source: 0001209191-22-021429 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,161,027 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.00 to $292.47, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 21, 2022 Filed Mar 22, 2022 19:41 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 828 | $293.07 | $242,660.30 |
DisclosureSEC source: 0001209191-22-020505 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,168,565 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.02 to $293.11, inclusive. Read SEC document |
| March 21, 2022 Filed Mar 22, 2022 19:41 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 34,417 | $292.41 | $10,063,943.80 |
DisclosureSEC source: 0001209191-22-020505 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,169,393 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.00 to $292.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 18, 2022 Filed Mar 21, 2022 17:12 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 21,357 | $289.21 | $6,176,722.04 |
DisclosureSEC source: 0001209191-22-020199 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,203,810 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $289.00 to $289.65, inclusive. Read SEC document |
| March 18, 2022 Filed Mar 21, 2022 17:12 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 110,871 | $288.42 | $31,977,524.69 |
DisclosureSEC source: 0001209191-22-020199 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,225,167 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $288.00 to $288.99, inclusive. Read SEC document |
| March 18, 2022 Filed Mar 21, 2022 17:12 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 77,772 | $287.56 | $22,364,116.32 |
DisclosureSEC source: 0001209191-22-020199 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,336,038 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $287.00 to $287.9997, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 15:48 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 49,320 | $284.86 | $14,049,196.56 |
DisclosureSEC source: 0001209191-22-019973 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,413,810 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $284.50 to $285.32, inclusive. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 15:48 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 84,767 | $283.93 | $24,067,894.31 |
DisclosureSEC source: 0001209191-22-019973 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,463,130 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $283.50 to $284.49, inclusive. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 15:48 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 85,913 | $283.06 | $24,318,361.95 |
DisclosureSEC source: 0001209191-22-019973 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,547,897 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $282.50 to $283.495, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 15:44 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 16,402 | $276.16 | $4,529,625.53 |
DisclosureSEC source: 0001209191-22-019093 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,633,810 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.00 to $276.43, inclusive. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 15:44 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 110,782 | $275.49 | $30,518,779.27 |
DisclosureSEC source: 0001209191-22-019093 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,650,212 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.00 to $275.99, inclusive. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 15:44 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 72,816 | $274.44 | $19,983,623.04 |
DisclosureSEC source: 0001209191-22-019093 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,760,994 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.00 to $274.99, inclusive. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 15:44 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 18,539 | $273.05 | $5,062,092.49 |
DisclosureSEC source: 0001209191-22-019093 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,833,810 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.95 to $273.37, inclusive. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 15:44 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,030 | $272.43 | $280,602.90 |
DisclosureSEC source: 0001209191-22-019093 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,852,349 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.855 to $272.79, inclusive. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 15:44 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 506 | $271.04 | $137,146.24 |
DisclosureSEC source: 0001209191-22-019093 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,853,379 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.735 to $271.61, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5) and (6) to this Form 4. Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 18:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 29,023 | $270.25 | $7,843,407.70 |
DisclosureSEC source: 0001209191-22-018748 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,853,885 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.00 to $270.75 , inclusive. Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 18:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 144,062 | $269.21 | $38,783,507.27 |
DisclosureSEC source: 0001209191-22-018748 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,882,908 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.00 to $269.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 19:02 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 21,840 | $269.05 | $5,875,986.48 |
DisclosureSEC source: 0001209191-22-018419 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,026,970 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.00 to $269.41, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 17:04 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 28,187 | $267.30 | $7,534,441.47 |
DisclosureSEC source: 0001209191-22-018106 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,048,810 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.00 to $267.68, inclusive. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 17:04 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 156,795 | $266.29 | $41,753,097.35 |
DisclosureSEC source: 0001209191-22-018106 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,076,997 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.00 to $266.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 17:39 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,525 | $267.50 | $675,432.45 |
DisclosureSEC source: 0001209191-22-017793 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,233,792 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.23 to $267.67, inclusive. Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 17:39 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 17,493 | $266.38 | $4,659,715.37 |
DisclosureSEC source: 0001209191-22-017793 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,236,317 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.00 to $266.93, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 18:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,435 | $263.29 | $1,430,975.72 |
DisclosureSEC source: 0001209191-22-016578 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,253,810 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.21 to $263.42, inclusive. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 18:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 109,667 | $262.69 | $28,807,875.90 |
DisclosureSEC source: 0001209191-22-016578 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,259,245 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.21 to $263.20, inclusive. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 18:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 77,335 | $261.90 | $20,253,649.83 |
DisclosureSEC source: 0001209191-22-016578 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,368,912 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.21 to $262.205, inclusive. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 18:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 17,563 | $260.69 | $4,578,445.78 |
DisclosureSEC source: 0001209191-22-016578 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,446,247 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.21 to $261.205, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| December 30, 2021 Filed Jan 3, 2022 15:01 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,614 | $279.55 | $1,010,275.63 |
DisclosureSEC source: 0001209191-22-000027 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,463,810 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $279.50 to $279.895, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 16:25 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,570 | $279.53 | $997,924.96 |
DisclosureSEC source: 0001209191-21-071351 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,467,424 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $279.50 to $279.88, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 21:19 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 4,920 | $283.06 | $1,392,635.52 |
DisclosureSEC source: 0001209191-21-070263 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,470,994 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $282.715 to $283.51, inclusive. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 21:19 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 10,579 | $281.79 | $2,981,035.25 |
DisclosureSEC source: 0001209191-21-070263 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,475,914 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $281.50 to $282.49, inclusive. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 21:19 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 29,571 | $280.90 | $8,306,346.05 |
DisclosureSEC source: 0001209191-21-070263 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,486,493 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $280.50 to $281.495, inclusive. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 21:19 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 132,546 | $279.82 | $37,088,756.63 |
DisclosureSEC source: 0001209191-21-070263 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,516,064 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $279.50 to $280.495, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 11,377 | $275.23 | $3,131,257.58 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 9 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,648,610 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.13 to $275.38, inclusive. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 24,067 | $274.62 | $6,609,159.21 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,659,987 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.06 to $274.99, inclusive. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 26,223 | $273.44 | $7,170,338.45 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,684,054 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.03 to $274.02, inclusive. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 36,370 | $272.66 | $9,916,607.83 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,710,277 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.03 to $273.0292, inclusive. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 51,126 | $271.52 | $13,881,936.02 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,746,647 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.03 to $272.02, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.